ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon Print
Retail Trade

MatsukiyoCocokara & Co.

Business Summary

MatsukiyoCocokara & Co. engages in the management and supervision of its group companies that are in drugstore and pharmacy operations. It operates through the following segments: Retail Business, Wholesale Business, and Management Support. The Retail Business segment deals with the retail sales of pharmaceutical and related products. The Wholesale Business segment operates as a wholesale distributor of medicines and miscellaneous daily goods, and offers franchising services. The Management Support segment manages the Group and indirect operations. The company was founded on October 1, 2007 and is headquartered in Matsudo, Japan.

Financial Highlights

Mar 2022 JPYUSD
Gross Profit225,434M2,006.12M
Operating income41,849M372.41M
Income before tax49,629M441.64M
Net income34,589M307.80M
Diluted EPS283.052.51
Dividends Per Share750.66
Total Assets656,735M5,410.79M
Total liabilities192,389M1,585.07M
Total equity464,317M3,825.47M
Operating cash flow39,812M354.28M
Currency in JPYCurrency in USD

Historical Data

 Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022
Revenue 558,879M 575,991M 590,593M 544,737M 729,969M
Gross Profit 161,502M 171,249M 181,036M 162,663M 225,434M
Operating income 33,567M 36,029M 37,554M 31,820M 41,849M
Income before tax 34,418M 37,369M 39,078M 32,666M 49,629M
Net income 22,755M 25,035M 26,176M 21,602M 34,589M
EBITDA 41,271M 44,262M 45,957M 40,398M 56,710M
Diluted EPS 214.92 239.32 254.93 210.36 283.05
Dividends Per Share 55 65 70 70 75
Total Assets 314,178M 318,324M 351,809M 368,936M 656,735M
Total liabilities 109,303M 109,050M 122,499M 122,711M 192,389M
Total equity 204,871M 209,269M 229,304M 246,220M 464,317M
Operating cash flow 27,938M 21,897M 24,764M 25,875M 39,812M
 Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022
Revenue 5,042.55M 5,194.03M 5,431.95M 5,136.24M 6,495.96M
Gross Profit 1,457.17M 1,544.24M 1,665.06M 1,533.72M 2,006.12M
Operating income 302.86M 324.89M 345.40M 300.02M 372.41M
Income before tax 310.54M 336.97M 359.41M 308.00M 441.64M
Net income 205.30M 225.75M 240.75M 203.68M 307.80M
EBITDA 372.37M 399.13M 422.68M 380.90M 504.66M
Diluted EPS 1.93 2.15 2.34 1.98 2.51
Dividends Per Share 0.49 0.58 0.64 0.66 0.66
Total Assets 2,954.18M 2,875.94M 3,258.84M 3,338.78M 5,410.79M
Total liabilities 1,027.76M 985.22M 1,134.72M 1,110.50M 1,585.07M
Total equity 1,926.38M 1,890.67M 2,124.07M 2,228.23M 3,825.47M
Operating cash flow 252.07M 197.45M 227.76M 243.97M 354.28M

Valuation Measures

Mar 2022
Operating margin5.73%
Profit margin4.73%

Key executives

  • President & Representative Director: Kiyoo Matsumoto
  • Manager-Finance & Accounting: Hiroshi Nishida
  • Senior Manager-Information System: Hidesato Hiramatsu
  • Representative Director & Vice President: Atsushi Tsukamoto
  • Executive Officer & Head-Kyushu Sales: Takao Watanabe


  • The Chiba Bank, Ltd. (3.5%)
  • Nomura Asset Management Co., Ltd. (3.2%)
  • Columbia Management Investment Advisers LLC (2.4%)
  • The Vanguard Group, Inc. (2.1%)
  • Eisai Co., Ltd. (1.9%)
  • MatsukiyoCocokara & Co. (1.6%)
  • Matsukiyococokara Employee Stock Ownership Plan (1.5%)

Contact Details

Related Companies

  • Matsukiyococokara Restricted Stock Compensation Plan
  • Matsukiyococokara Employee Stock Ownership Plan
  • Matsumotokiyoshi Insurance Service Co., Ltd.
  • Matsumotokiyoshi Wholesale Co., Ltd.
  • Matsumotokiyoshi Pharmacies Co., Ltd.
  • Matsumotokiyoshi Kyushu Sales Co., Ltd.
  • Matsumotokiyoshi Hd Restricted Stock Compensation Plan
  • Matsumotokiyoshi Holdings Employee Incentive Plan
  • Matsumotokiyoshi Holdings Board Incentive Plan
  • Daruma Drug Co., Ltd.
  • Matsumotokiyoshi Kou-Shin-Etsu Japan Co., Ltd.
  • Yukari Kokoku KK
  • MK Higashinihon Hambai KK
  • Tobu Drug KK
  • MK Planning KK
  • Moris Retail KK
  • Koyo Yakuhin Co., Ltd.
  • Sugiura Co., Ltd.
  • Itayama Medico Co. Ltd.
  • Nakajima Family Yakkyoku KK
  • Shimeno Yakkyoku KK
  • Matsumotokiyoshi Asset Management Co., Ltd.
  • Love Drugs Co., Ltd.
  • Matsumotokiyoshi Co., Ltd.
  • Midoriyakuhin Co., Ltd.


    Last Updated on 3 Feb, 2023

    Discover the all new Nikkei Asia app

    • Take your reading anywhere with offline reading functions
    • Never miss a story with breaking news alerts
    • Customize your reading experience

    Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

    Celebrate our next chapter
    Free access for everyone - Sep. 30

    Find out more